南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

去泛素化酶UCHL1通过稳定CaMKII-δ蛋白,增加心房颤动的易感性

The Deubiquitinase UCHL1 Drives Susceptibility to Atrial Fibrillation by Stabilizing CaMKII‐δ

Hai‐Lian Bi, Yu‐Hui Gu, Kai‐Wen Ren, Xiao‐Hong Yu, Yun‐Long Xia, Xiao‐Lei Yang, Hui‐Hua Li

Journal:Advanced Science

IF:14.1

DOI:10.1002/advs.77855

PMID:42811467

Published:2026-09-29

research field:肿瘤学分子生物学癌症遗传学

Abstract

Atrial fibrillation (AF) is a common arrhythmia associated with calcium (Ca 2+ ) dysregulation. Ca 2+ /calmodulin‐dependent protein kinase II‐δ (CaMKII‐δ) links Ca 2+ handling to arrhythmogenesis, but whether deubiquitination regulates its stability in AF remains unclear. We established an AF model by infusing angiotensin II (Ang II) for 3 weeks in atrial cardiomyocyte‐specific ubiquitin C‐terminal hydrolase L1 (UCHL1)‐knockout (CKO) and recombinant adeno‐associated virus serotype 9 (rAAV9)‐UCHL1‐overexpressing mice. UCHL1 was markedly upregulated in atria from Ang II‐infused mice and patients with AF. UCHL1‐CKO attenuated Ang II‐induced atrial remodeling and AF susceptibility, reduced CaMKII‐δ stability, and improved Ca 2+ handling, whereas UCHL1 overexpression produced the opposite effects. Mechanistically, UCHL1 bound to and deubiquitinated CaMKII‐δ at K251, preventing proteasomal degradation and thereby enhancing ryanodine receptor type 2 (RyR2) phosphorylation and Ca 2+ mishandling. The ubiquitination‐deficient CaMKII‐δ‐K251R mutant aggravated AF, whereas CaMKII‐δ knockdown or inhibition reduced the proarrhythmic effects of UCHL1 overexpression. Furthermore, the UCHL1 inhibitor 6RK73 reduced AF inducibility in mice. These findings identify UCHL1‐mediated stabilization of the CaMKII‐δ–RyR2 axis as a mechanism of AF and support UCHL1 as a potential therapeutic target. UCHL1 is highly upregulated in mice and patients with AF. UCHL1 directly binds to and removes K48‐linked polyubiquitin chains from CaMKII‐δ at K251 and enhances CaMKII‐δ stability, which activates RyR2, disrupts Ca 2+ handling, and promotes AF. These findings establish UCHL1 as a critical regulator of CaMKII‐δ stability and AF‐related Ca 2+ handling. Targeting the UCHL1‐CaMKII‐δ pathway may offer a therapeutic approach for AF.

本文使用的Yeasen产品

购物车
客服
转染试用